Clinical trials
Thrombocytopenia trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2011 | 2 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 8 |
| Terminated | 8 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Centre Hospitalier Universitaire de Saint Etienne | 3 |
| Novartis Pharmaceuticals | 3 |
| University Hospital, Bordeaux | 3 |
| CTI BioPharma | 2 |
| Eisai Inc. | 2 |
| Nantes University Hospital | 2 |
| Takeda | 2 |
| University Hospital, Lille | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 46 |
| Purpura, Thrombocytopenic, Idiopathic | 8 |
| Myelodysplastic Syndromes | 6 |
| Anemia | 4 |
| Hemorrhage | 4 |
| Primary Myelofibrosis | 4 |
| Purpura | 4 |
| Hematologic Diseases | 3 |
| Hepatitis C | 3 |
| Splenomegaly | 3 |
Trials
Showing 76 to 46 of 46. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.